Testing trazodone for sleep apnea
Part of Brain & nervous system, Lungs & breathing clinical trials.
This trial tests whether the medication trazodone can help people with moderate to severe obstructive sleep apnea (OSA). If you have OSA and are not taking certain medications or have other sleep disorders, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have moderate or severe sleep apnea (AHI score of 15 or higher per hour).
- You are generally healthy and do not have major organ problems.
- You are not taking certain medications that affect breathing, like opioids, barbiturates, or some antidepressants (SNRIs/SSRIs).
- You do not have other sleep disorders like restless legs, narcolepsy, or sleepwalking.
- You do not have conditions that affect sleep apnea, such as heart failure, nerve or muscle disease, or low potassium or magnesium levels.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether atomoxetine and DAW2022 can improve how severe obstructive sleep apnea is. It may help by changing breathing patterns during sleep, measured through physiology tests.
This trial studies a “rescue” set of medicines for obstructive sleep apnea when two common treatments haven’t worked well enough. If you still have frequent breathing pauses during sleep, the study may test whether these medicines can reduce them and improve safety and symptoms.
This early study tests a medicine that is meant to improve how your brain and breathing muscles work during sleep for obstructive sleep apnea (OSA). If you qualify, you would be monitored during sleep to see whether the treatment changes breathing events and oxygen levels.
This trial tests a device that uses mild electrical pulses to help keep your airway open while you sleep. It's for people with moderate sleep apnea who have trouble using a CPAP machine.
This study tests acetazolamide (a medicine that changes breathing chemistry) to see how it affects sleep quality and neurocognitive (brain/memory/attention) outcomes in adults with untreated moderate to severe sleep apnea. You may be eligible if you have significant sleep apnea but do not have certain safety risks or need to start standard sleep apnea treatment right away.
This trial tests a type of mouth and throat therapy to see if it can help people with mild to moderate sleep apnea who can't or don't want to use a CPAP machine. It might be an option if you want a non-machine treatment for your sleep apnea.
Hear when a new Obstructive Sleep Apnea trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.